Research Highlights

MTN is excited to announce that MTN-033 has completed enrollment.

 

Microbicide Trials Network Research Prominent at 2018 HIV R4P.

 

MTN is excited to announce the launch of MTN-037.

 

MTN-033 is launched.

 

MTN presented preliminary results from the HOPE study (MTN-025) at CROI 2018.

 

The first-ever study of dapivirine gel as a rectal microbicide has begun.

 

Study on a vaginal ring for both HIV and pregnancy prevention completed.


Source URL: https://mtnstopshiv.org/research-highlights